Quinn @KQuinnRheum @petercgrayson et al. FDG-PET is not particularly useful in monitoring GCA on tocilizumab. Toc reduces but often not eliminate PET inflammation. PET activity does not predict relapse or vascular progression @RheumNow #ACR24 Abstr#0742 https://t.co/1qcJCGV118 https://t.co/6mBCgcbYo6
Links:
Use of FDG-PET to Monitor Disease Activity in Patients with Giant Cell Arteriti…
https://acrabstracts.org/abstract/use-of-fdg-pet-to-monitor-disease-activity-in…
16-11-2024